Sign in
STIM Stock Price, Chart, Stats & News
Neuronetics, Inc.
Save
Neuronetics, Inc. (STIM) does not currently pay a dividend.
190.67M
Market cap
–
Current P/E
–
Forward P/E
STIM chart
Fundamentals
Gross margin | 48.48% |
Operating margin | -21.08% |
Pretax margin | -26.15% |
Net margin | -26.15% |
Effective tax rate | – |
ROA | -27.55% |
ROE | -138.87% |
D/E | 4.04x |
Interest coverage ratio | -3.74x |
STIM valuation
P/E | – |
P/S | 0.60x |
P/B | 3.96x |
P/CF | -4.35x |
P/FCF | -4.22x |
P/OCF | -4.35x |
PEG | -0.08x |
EV multiple | -1.19x |
About
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U. S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder.
Similar securities
Based on sector and market capitalization
Report issue